Compare WLKP & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WLKP | CERT |
|---|---|---|
| Founded | 2014 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Retail: Computer Software & Peripheral Equipment |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 778.9M | 860.9M |
| IPO Year | 2014 | 2020 |
| Metric | WLKP | CERT |
|---|---|---|
| Price | $22.60 | $5.88 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $11.67 |
| AVG Volume (30 Days) | 27.1K | ★ 4.5M |
| Earning Date | 05-01-2026 | 05-11-2026 |
| Dividend Yield | ★ 8.32% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,166,695,000.00 | $418,838,000.00 |
| Revenue This Year | $19.48 | $4.18 |
| Revenue Next Year | $5.24 | $5.39 |
| P/E Ratio | $15.30 | ★ N/A |
| Revenue Growth | 2.71 | ★ 8.75 |
| 52 Week Low | $17.75 | $5.19 |
| 52 Week High | $23.82 | $15.38 |
| Indicator | WLKP | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 53.65 | 44.55 |
| Support Level | $21.72 | N/A |
| Resistance Level | $22.49 | $7.52 |
| Average True Range (ATR) | 0.51 | 0.30 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 67.91 | 56.10 |
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.